CN101229170A - 米氮平用于治疗睡眠障碍的用途 - Google Patents

米氮平用于治疗睡眠障碍的用途 Download PDF

Info

Publication number
CN101229170A
CN101229170A CNA2008100056868A CN200810005686A CN101229170A CN 101229170 A CN101229170 A CN 101229170A CN A2008100056868 A CNA2008100056868 A CN A2008100056868A CN 200810005686 A CN200810005686 A CN 200810005686A CN 101229170 A CN101229170 A CN 101229170A
Authority
CN
China
Prior art keywords
mirtazapine
treatment
sleep
sleep disorders
dosage unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2008100056868A
Other languages
English (en)
Chinese (zh)
Inventor
G·S·F·鲁伊格特
F·范丹伯格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon NV filed Critical Organon NV
Publication of CN101229170A publication Critical patent/CN101229170A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CNA2008100056868A 2000-02-11 2001-02-06 米氮平用于治疗睡眠障碍的用途 Pending CN101229170A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200499.2 2000-02-11
EP00200499 2000-02-11

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN01803934A Division CN1395487A (zh) 2000-02-11 2001-02-06 米氮平用于治疗睡眠障碍的用途

Publications (1)

Publication Number Publication Date
CN101229170A true CN101229170A (zh) 2008-07-30

Family

ID=8171013

Family Applications (2)

Application Number Title Priority Date Filing Date
CNA2008100056868A Pending CN101229170A (zh) 2000-02-11 2001-02-06 米氮平用于治疗睡眠障碍的用途
CN01803934A Pending CN1395487A (zh) 2000-02-11 2001-02-06 米氮平用于治疗睡眠障碍的用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN01803934A Pending CN1395487A (zh) 2000-02-11 2001-02-06 米氮平用于治疗睡眠障碍的用途

Country Status (25)

Country Link
US (1) US6933293B2 (https=)
EP (4) EP1658850A1 (https=)
JP (1) JP5039994B2 (https=)
KR (1) KR20020069371A (https=)
CN (2) CN101229170A (https=)
AR (1) AR027394A1 (https=)
AT (1) ATE317261T1 (https=)
AU (1) AU780439B2 (https=)
BR (1) BR0108261A (https=)
CA (1) CA2396209C (https=)
CO (1) CO5271706A1 (https=)
CZ (1) CZ302368B6 (https=)
DE (1) DE60117122T2 (https=)
DK (1) DK1257278T3 (https=)
ES (1) ES2258071T3 (https=)
HK (1) HK1049122B (https=)
HU (1) HUP0204391A3 (https=)
IL (2) IL150290A0 (https=)
NO (1) NO328007B1 (https=)
PE (1) PE20011080A1 (https=)
PL (1) PL206073B1 (https=)
RU (1) RU2270680C2 (https=)
SK (1) SK287396B6 (https=)
WO (1) WO2001058453A1 (https=)
ZA (1) ZA200205238B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040152055A1 (en) * 2003-01-30 2004-08-05 Gliessner Michael J.G. Video based language learning system
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
EP1689371A2 (en) * 2003-11-25 2006-08-16 Aurobindo Pharma Limited Pharmaceutical compositions of mirtazapine
GB0417558D0 (en) * 2004-08-06 2004-09-08 Merck Sharp & Dohme Novel combination therapy
EP1806133A1 (en) * 2004-10-14 2007-07-11 Daikin Industries, Ltd. Method for modifying the ambience, and spray liquid and sprayer used in the method
JP2006137748A (ja) * 2004-10-14 2006-06-01 Daikin Ind Ltd 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置
JP2007284363A (ja) * 2006-04-13 2007-11-01 Daikin Ind Ltd 噴霧剤
CN101679431B (zh) 2007-04-11 2013-08-14 Msd欧斯股份有限公司 制备四环苯并氮杂卓的对映异构体的方法
WO2016138357A1 (en) 2015-02-27 2016-09-01 Kindred Biosciences, Inc. Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
DE69307908T2 (de) * 1992-10-07 1997-07-10 Akzo Nobel Nv Verfahren zur trennung von enantiomeren aus einer racemischen mischung
EP0813873B1 (en) 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
JP2001522891A (ja) * 1997-11-14 2001-11-20 アクゾ・ノベル・エヌ・ベー 睡眠時無呼吸を治療するためのミルタザピンの使用

Also Published As

Publication number Publication date
ES2258071T3 (es) 2006-08-16
PE20011080A1 (es) 2001-10-18
JP2003522147A (ja) 2003-07-22
SK287396B6 (sk) 2010-08-09
DE60117122D1 (de) 2006-04-20
US6933293B2 (en) 2005-08-23
CZ20022330A3 (cs) 2002-11-13
WO2001058453A1 (en) 2001-08-16
HK1049122B (en) 2006-04-21
IL150290A (en) 2010-12-30
US20030022888A1 (en) 2003-01-30
HUP0204391A2 (en) 2003-05-28
CA2396209A1 (en) 2001-08-16
AU780439B2 (en) 2005-03-24
CO5271706A1 (es) 2003-04-30
RU2270680C2 (ru) 2006-02-27
PL356721A1 (en) 2004-06-28
PL206073B1 (pl) 2010-06-30
EP1658850A1 (en) 2006-05-24
DK1257278T3 (da) 2006-06-12
NO20023803D0 (no) 2002-08-09
DE60117122T2 (de) 2006-07-27
ATE317261T1 (de) 2006-02-15
EP1257278B1 (en) 2006-02-08
ZA200205238B (en) 2003-09-29
AR027394A1 (es) 2003-03-26
RU2002124141A (ru) 2004-03-10
HK1049122A1 (en) 2003-05-02
IL150290A0 (en) 2002-12-01
EP1257278A1 (en) 2002-11-20
NO328007B1 (no) 2009-11-09
CZ302368B6 (cs) 2011-04-13
SK11442002A3 (sk) 2003-02-04
NO20023803L (no) 2002-10-09
KR20020069371A (ko) 2002-08-30
EP1656937A1 (en) 2006-05-17
BR0108261A (pt) 2003-03-05
AU3024701A (en) 2001-08-20
EP2283840A1 (en) 2011-02-16
HUP0204391A3 (en) 2005-03-29
JP5039994B2 (ja) 2012-10-03
CA2396209C (en) 2009-09-01
CN1395487A (zh) 2003-02-05

Similar Documents

Publication Publication Date Title
Gillin et al. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial
JP3660587B2 (ja) 線維筋痛及び慢性疲労症候群の治療における酪酸塩誘導体
US6335021B1 (en) Composition for controlling mood disorders in healthy individuals
Ware et al. Effects on sleep: a double-blind study comparing trimipramine to imipramine in depressed insomniac patients
KR101841442B1 (ko) 주우울증 환자들에 있어서 체중 감량 치료를 제공하는 방법
US12485100B2 (en) Treatment of menstrual cycle-induced symptoms
US20080182890A1 (en) Methods of using low-dose doxepin for the improvement of sleep
RU2268725C2 (ru) Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств
CN101229170A (zh) 米氮平用于治疗睡眠障碍的用途
JPH0920666A (ja) 成熟遅延および類似疾患の治療用医薬組成物
JPS63243028A (ja) 基本的うつ病を軽減するためのうつ病治療剤
TWI297607B (en) The use of mirtazapine for the treatment of sleep disorders and pharmaceutical composition comprising mirtazapine
HK1087356A (en) The use of mirtazapine for the treatment of sleep disorders
HK1087359A (en) The use of mirtazapine for the treatment of sleep disorders
HK1150978A (en) The use of mirtazapine for the treatment of sleep disorders
MXPA02006710A (en) The use of mirtazapine for the treatment of sleep disorders
JPH03246225A (ja) メランコリーうつ病の治療法
Pollack et al. Variables in the clinical evaluation of a hypnotic drug with a clinical evaluation of glutethimide

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: Holland

Applicant after: MSD Oss Bv

Address before: Holland

Applicant before: Organon NV

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: ORGANON NV TO: MSD OS CO., LTD.

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20080730